Patients with thoracic aortic aneurysms that lead to acute aortic dissections are 12 times more likely to have duplications in the DNA in a region of chromosome 16 (16p13.1) than those without the disease, according to a ...
Jun 16, 2011
0
0
(Medical Xpress) -- Researchers in the Keck School of Medicine of the University of Southern California (USC), together with scientists in Beijing, China, have discovered a chromosomal mutation responsible for a very rare ...
Jun 3, 2011
0
0
A team of researchers is beginning to see exactly what the response to threats looks like in the brain at the cellular and molecular levels.
May 3, 2011
0
0
Genetic factors are a small but significant contributor to severe depression that does not respond to standard therapy, according to researchers at Vanderbilt University Medical Center and Massachusetts General Hospital.
May 15, 2024
0
25
Molecular tests and other screening tools can lessen the risk of potentially fatal reactions to antiseizure medications that millions of Americans take for epilepsy and other conditions, but skin rashes still require speedy ...
May 15, 2024
0
2
Ultrasound imaging offers a valuable and noninvasive way to find and monitor cancerous tumors. However, much of the most crucial information about a cancer, such as specific cell types and mutations, cannot be learned from ...
May 13, 2024
0
0
When it comes to improving the lives of children with genetic conditions, medical research often focuses solely on the children. But there is an equally important population in need of research that a faculty member at the ...
May 10, 2024
0
0
When cancer strikes, you could easily go into debt, even with health insurance in place, according to a new survey from the American Cancer Society.
May 10, 2024
1
0
"Childhood" and "dementia" are two words we wish we didn't have to use together. But sadly, around 1,400 Australian children and young people live with currently untreatable childhood dementia.
Apr 26, 2024
0
1
A test to gauge if it's safe to prescribe a patient an addictive opioid may have been approved too soon by the U.S. Food and Drug Administration, claims a letter sent to the agency by a group of experts.
Apr 5, 2024
0
0
